# PHASE 5: CANCER CELL ANALYSIS - Detailed Guide

## Overview
Phase 5 assesses oncolytic potential and cancer cell targeting efficacy.

## Implementation Details

### Key Components

1. **Oncolytic Potential Assessment**
   - Oncolytic score calculation
   - Replication capability
   - Entry efficiency
   - Potential classification

2. **Cancer Cell Targeting**
   - Analysis for multiple cell types
   - Targeting scores per cell type
   - Receptor affinity assessment
   - Entry probability

3. **Selectivity Analysis**
   - Cancer vs normal cell selectivity
   - Selectivity score
   - Therapeutic window calculation

4. **Efficacy Prediction**
   - Overall efficacy score
   - Dose requirement estimation
   - Treatment duration prediction

5. **Safety Assessment**
   - Safety score
   - Off-target risk
   - Safety classification
   - Monitoring recommendations

### Usage

```python
from src.cancer.analyzer import CancerAnalyzer
from src.core.config import Config

config = Config('config.yaml')
analyzer = CancerAnalyzer(config)
cancer_results = analyzer.analyze(genome_results, structure_results, cell_results)
```

### Output Metrics

- Oncolytic potential score
- Cancer cell targeting (per cell type)
- Selectivity score
- Efficacy prediction
- Safety assessment

### Cancer Cell Types Analyzed

- HeLa (cervical cancer)
- MCF-7 (breast cancer)
- A549 (lung cancer)
- HepG2 (liver cancer)

### Pharmaceutical-Grade Standards

- Multi-cell type analysis
- Statistical validation
- Confidence intervals
- Safety-focused assessment

### Therapeutic Implications

- Determines oncolytic potential
- Predicts therapeutic efficacy
- Assesses safety profile
- Guides clinical trial design

